Director, Diagnostic Strategy, Medical Affairs @ (April 2025 - Present)
Precision Medicine @ Boundless Bio (August 2024 - April 2025)
Sr. Director, MSL Team Lead @ Labcorp Oncology Drug Development (August 2022 - August 2024)
National Biomarker Testing Liaison Lead @ (December 2019 - August 2022)
Associate Director, Commercial Programs @ (August 2018 - December 2019)
Sr. Manager, Clinical Collaborations @ (September 2017 - August 2018)
Manager, Clinical Collaborations @ (April 2015 - September 2017)
Account Executive @ (February 2014 - April 2015)
Sr. Oncology Sales Specialist @ (July 2012 - February 2014)
Clinical Oncology Specialist @ (January 2006 - May 2012)
Clinical Research Technologist @ (January 2006 - May 2007)
Molecular Pathology- Research Associate IV @ (May 2005 - January 2006)
MWR Operations Specialist @ (May 1998 - June 2004)
Maureen Cooper Education
City University of New York-College of Staten Island
B.S. (Bioinformatics)
2001-2004
Maureen Cooper Skills
Clinical Trials
Cell Culture
PCR
Research
Medicine
Biotechnology
Oncology
Infectious Diseases
Lifesciences
Medical Devices
Pharmaceutical Industry
Immunology
Clinical Research
Molecular Biology
Life Sciences
Cancer
Healthcare
Personal Development
High Performer
Leadership
Employee Engagement
Thought Leadership
Lifelong Learning
Decision-Making
Project Management
Sales
Program Management
Maureen Cooper Summary
Maureen Cooper, based in Canonsburg, PA, US, is currently a Sr. Director, Diagnostic Strategy, Medical Affairs at Madrigal Pharmaceuticals. Maureen Cooper brings experience from previous roles at Madrigal Pharmaceuticals, Boundless Bio, Labcorp Oncology Drug Development and Foundation Medicine. Maureen Cooper holds a 2001 - 2004 B.S. in Bioinformatics @ City University of New York-College of Staten Island. With a robust skill set that includes Clinical Trials, Cell Culture, PCR, Research, Medicine and more. Maureen Cooper has 4 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Maureen Cooper?
Find contact details for 700 million professionals.